Chemical exacerbates common bacterial infection, study says

A naturally produced chemical exacerbates infection by a common bacteria, rendering the infection significantly harder for the body to clear, according to new Cornell cross-campus research.

'Global City Sampling Day' launches Weill antimicrobial study

Spanning six continents, 32 countries and 54 cities, more than 12,000 samples of DNA, RNA and microbes from surfaces in subways, buses, airports and other well-traveled public meeting spaces were collected June 21.

NIH provides $2.3M grant for FeverPhone development

The National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering has awarded Cornell a four-year, $2.3 million grant to develop FeverPhone, which will diagnose six febrile diseases in the field.

Cornell to launch new Master of Public Health program

Starting in the fall 2017 semester, Cornell University will offer a Master of Public Health degree with a focus on epidemiology, infectious disease, food systems and sustainability.

In doctors we trust – especially when they admit to bias

A doctor's guidance may reassure us more than we realize – especially if she says she is likely to recommend treatment in her field of expertise. The Cornell research was published in the Proceedings of the National Academy of Sciences.

Q&A: David M. Lodge on Atkinson Center priorities, impacts

David M. Lodge, the Francis J. DiSalvo Director of the Atkinson Center for a Sustainable Future discusses his priorities in the coming year and how the center is making an impact around the world.

Reunion forum showcases Institute for Healthy Futures

Rohit Verma highlighted the work of the Cornell Institute for Healthy Futures during a Reunion Weekend forum June 11 hosted by the Classes of ’71 and ’76.

Consumers sour on milk exposed to LED light

Cornell researchers in the Department of Food Science found exposure to light-emitting diode (LED) sources for even a few hours degrades the perceived quality of fluid milk more than microbes.

Early assessment, drug switch improves cancer treatment

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response: new research from Weill Cornell Medicine.